Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed
Investigating the daily life experiences of patients using Continuous Glucose Monitoring (CGM) can highlight the benefits and barriers in using this system for people with type 1 diabetes (T1D). Semi-structured qualitative interviews were conducted with the caregivers of 10 children aged <9 years...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/552d601abcef4f5db01bbda5719b9c4b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:552d601abcef4f5db01bbda5719b9c4b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:552d601abcef4f5db01bbda5719b9c4b2021-12-02T23:33:37ZBenefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed2374-374310.1177/23743735211056523https://doaj.org/article/552d601abcef4f5db01bbda5719b9c4b2021-12-01T00:00:00Zhttps://doi.org/10.1177/23743735211056523https://doaj.org/toc/2374-3743Investigating the daily life experiences of patients using Continuous Glucose Monitoring (CGM) can highlight the benefits and barriers in using this system for people with type 1 diabetes (T1D). Semi-structured qualitative interviews were conducted with the caregivers of 10 children aged <9 years, all of whom had been treated for T1D and had used CGM >6 months. These interviews were analyzed using the content analysis approach and from these interviews, four meta themes emerged: metabolic control, barriers to CGM use, CGM use in daily life, and comparison with fingersticks. Families reported the following as benefits of CGM: pain relief, better hypoglycemia and hyperglycemia management, increased control over diet and social life, reduced worries at school and during the night, and convenience in entrusting the child to the care of others. Cost, concerns related to accuracy and reliability of measurements, insertion, adhesion and removal issues all emerged as barriers to CGM use. The most prominent issue was the economic burden of CGM. Families accept this burden, even though it is challenging, as their experiences in using CGM are positive and they feel that CGM is necessary for T1D management.Kağan Ege KarakuşSibel Sakarya MD, MPHGül Yeşiltepe Mutlu MDMetehan BerkkanSerra Muradoğlu MAEcem Can MSN, RNTuğba Gökçe BSNElif Eviz MDŞükrü Hatun MDSAGE PublishingarticleMedicine (General)R5-920ENJournal of Patient Experience, Vol 8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine (General) R5-920 |
spellingShingle |
Medicine (General) R5-920 Kağan Ege Karakuş Sibel Sakarya MD, MPH Gül Yeşiltepe Mutlu MD Metehan Berkkan Serra Muradoğlu MA Ecem Can MSN, RN Tuğba Gökçe BSN Elif Eviz MD Şükrü Hatun MD Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed |
description |
Investigating the daily life experiences of patients using Continuous Glucose Monitoring (CGM) can highlight the benefits and barriers in using this system for people with type 1 diabetes (T1D). Semi-structured qualitative interviews were conducted with the caregivers of 10 children aged <9 years, all of whom had been treated for T1D and had used CGM >6 months. These interviews were analyzed using the content analysis approach and from these interviews, four meta themes emerged: metabolic control, barriers to CGM use, CGM use in daily life, and comparison with fingersticks. Families reported the following as benefits of CGM: pain relief, better hypoglycemia and hyperglycemia management, increased control over diet and social life, reduced worries at school and during the night, and convenience in entrusting the child to the care of others. Cost, concerns related to accuracy and reliability of measurements, insertion, adhesion and removal issues all emerged as barriers to CGM use. The most prominent issue was the economic burden of CGM. Families accept this burden, even though it is challenging, as their experiences in using CGM are positive and they feel that CGM is necessary for T1D management. |
format |
article |
author |
Kağan Ege Karakuş Sibel Sakarya MD, MPH Gül Yeşiltepe Mutlu MD Metehan Berkkan Serra Muradoğlu MA Ecem Can MSN, RN Tuğba Gökçe BSN Elif Eviz MD Şükrü Hatun MD |
author_facet |
Kağan Ege Karakuş Sibel Sakarya MD, MPH Gül Yeşiltepe Mutlu MD Metehan Berkkan Serra Muradoğlu MA Ecem Can MSN, RN Tuğba Gökçe BSN Elif Eviz MD Şükrü Hatun MD |
author_sort |
Kağan Ege Karakuş |
title |
Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed |
title_short |
Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed |
title_full |
Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed |
title_fullStr |
Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed |
title_full_unstemmed |
Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed |
title_sort |
benefits and drawbacks of continuous glucose monitoring (cgm) use in young children with type 1 diabetes: a qualitative study from a country where the cgm is not reimbursed |
publisher |
SAGE Publishing |
publishDate |
2021 |
url |
https://doaj.org/article/552d601abcef4f5db01bbda5719b9c4b |
work_keys_str_mv |
AT kaganegekarakus benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed AT sibelsakaryamdmph benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed AT gulyesiltepemutlumd benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed AT metehanberkkan benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed AT serramuradogluma benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed AT ecemcanmsnrn benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed AT tugbagokcebsn benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed AT elifevizmd benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed AT sukruhatunmd benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed |
_version_ |
1718374051545612288 |